Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About Asthma Therapeutics
Increasing allergic rhinitis is a major factor for allergic asthma leading to increase in research for the development of allergic immunotherapies for the treatment of asthma. The global asthma therapeutics market will observe a moderate growth during the forecast period because of loss of patent exclusivity of the major drugs, allowing the entry of generics into the market. This will lead to the erosion of the market share of the major asthma drugs. However, the presence of late-stage pipeline molecules will drive the market. An increase in the prevalence of asthma and the use of combination drugs will drive the growth of the market during the forecast period.
Technavio’s analysts forecast the global asthma therapeutics market to grow at a CAGR of 4.31% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global asthma therapeutics market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the sales of brand-name, generic, and off-label drugs used for the prevention and treatment of asthma. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from patent expiries of marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Asthma Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AstraZeneca
• Boehringer Ingelheim
• F. Hoffmann-La Roche
• GSK
• Merck
Other prominent vendors
• ALK-Abello
• Amgen
• Array BioPharma
• Asmacure
• Astellas Pharma
• Atopix Therapeutics
• Axikin Pharmaceuticals
• Chiesi Farmaceutici
• Dynavax Technologies Corp.
• Horizon Pharma
• Hovione Scientia
• Invion
• Ivax
• Kissei Pharmaceutical
• Kyowa Hakko Kirin
• MediciNova
• Mitsubishi Tanabe Pharma Corporation
• Mundipharma
• Nycomed
• Oxagen Limited
• Palobiofarma
• Pearl Therapeutics
• Pharmaking
• Pharmaxis
• Pulmagen Therapeutics
• Regeneron Pharmaceuticals
• Revalesio
• RSPR Pharma AB
• SAMA Pharmaceuticals
• Sanofi
• Skyepharma
• SolAeroMed
• Stallergenes
• Sterna Biologicals
• Synairgen
• Theron Pharmaceuticals
• UCB Pharma
• Vectura
• Verona Pharma
• Whanin Pharmaceutical Company
Market driver
• Huge market potential for mAbs
• For a full, detailed list, view our report
Market challenge
• Increased preference for CAM
• For a full, detailed list, view our report
Market trend
• Innovative technologies for drug delivery
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Increasing allergic rhinitis is a major factor for allergic asthma leading to increase in research for the development of allergic immunotherapies for the treatment of asthma. The global asthma therapeutics market will observe a moderate growth during the forecast period because of loss of patent exclusivity of the major drugs, allowing the entry of generics into the market. This will lead to the erosion of the market share of the major asthma drugs. However, the presence of late-stage pipeline molecules will drive the market. An increase in the prevalence of asthma and the use of combination drugs will drive the growth of the market during the forecast period.
Technavio’s analysts forecast the global asthma therapeutics market to grow at a CAGR of 4.31% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global asthma therapeutics market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the sales of brand-name, generic, and off-label drugs used for the prevention and treatment of asthma. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from patent expiries of marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Asthma Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AstraZeneca
• Boehringer Ingelheim
• F. Hoffmann-La Roche
• GSK
• Merck
Other prominent vendors
• ALK-Abello
• Amgen
• Array BioPharma
• Asmacure
• Astellas Pharma
• Atopix Therapeutics
• Axikin Pharmaceuticals
• Chiesi Farmaceutici
• Dynavax Technologies Corp.
• Horizon Pharma
• Hovione Scientia
• Invion
• Ivax
• Kissei Pharmaceutical
• Kyowa Hakko Kirin
• MediciNova
• Mitsubishi Tanabe Pharma Corporation
• Mundipharma
• Nycomed
• Oxagen Limited
• Palobiofarma
• Pearl Therapeutics
• Pharmaking
• Pharmaxis
• Pulmagen Therapeutics
• Regeneron Pharmaceuticals
• Revalesio
• RSPR Pharma AB
• SAMA Pharmaceuticals
• Sanofi
• Skyepharma
• SolAeroMed
• Stallergenes
• Sterna Biologicals
• Synairgen
• Theron Pharmaceuticals
• UCB Pharma
• Vectura
• Verona Pharma
• Whanin Pharmaceutical Company
Market driver
• Huge market potential for mAbs
• For a full, detailed list, view our report
Market challenge
• Increased preference for CAM
• For a full, detailed list, view our report
Market trend
• Innovative technologies for drug delivery
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
